121 related articles for article (PubMed ID: 8257858)
1. Positron emission tomography of thyroid masses.
Adler LP; Bloom AD
Thyroid; 1993; 3(3):195-200. PubMed ID: 8257858
[TBL] [Abstract][Full Text] [Related]
2. Determination of malignancy of thyroid nodules with positron emission tomography.
Bloom AD; Adler LP; Shuck JM
Surgery; 1993 Oct; 114(4):728-34; discussion 734-5. PubMed ID: 8211687
[TBL] [Abstract][Full Text] [Related]
3. Fluorine-18-fluorodeoxyglucose PET versus thallium-201 scintigraphy evaluation of thyroid tumors.
Uematsu H; Sadato N; Ohtsubo T; Tsuchida T; Nakamura S; Sugimoto K; Waki A; Takahashi N; Yonekura Y; Tsuda G; Saito H; Hayashi N; Yamamoto K; Ishii Y
J Nucl Med; 1998 Mar; 39(3):453-9. PubMed ID: 9529291
[TBL] [Abstract][Full Text] [Related]
4. Fluorine-18-fluorodeoxyglucose positron emission tomography in the preoperative assessment of thyroid nodules in an endemic goiter area.
Kresnik E; Gallowitsch HJ; Mikosch P; Stettner H; Igerc I; Gomez I; Kumnig G; Lind P
Surgery; 2003 Mar; 133(3):294-9. PubMed ID: 12660642
[TBL] [Abstract][Full Text] [Related]
5. 18F-fluorodeoxyglucose uptake in thyroid from positron emission tomogram (PET) for evaluation in cancer patients: high prevalence of malignancy in thyroid PET incidentaloma.
Kim TY; Kim WB; Ryu JS; Gong G; Hong SJ; Shong YK
Laryngoscope; 2005 Jun; 115(6):1074-8. PubMed ID: 15933524
[TBL] [Abstract][Full Text] [Related]
6. [Four patients with incidentalomas of the thyroid discovered on 18-fluoro-deoxyglucose positron-emission tomography (FDG-PET)].
Noordzij MJ; de Heide LJ; Links TP; Jager PL; Wolfenbuttel BH
Ned Tijdschr Geneeskd; 2007 Oct; 151(42):2337-41. PubMed ID: 18064937
[TBL] [Abstract][Full Text] [Related]
7. Clinical relevance of thyroid fluorodeoxyglucose-whole body positron emission tomography incidentaloma.
Van den Bruel A; Maes A; De Potter T; Mortelmans L; Drijkoningen M; Van Damme B; Delaere P; Bouillon R
J Clin Endocrinol Metab; 2002 Apr; 87(4):1517-20. PubMed ID: 11932274
[TBL] [Abstract][Full Text] [Related]
8. Comparison of F-18 FDG to I-123 and I-131 scans in thyroid carcinoma.
Bakheet SM; Powe JE; Hammami MM; Ahmed M
Clin Nucl Med; 1997 Jun; 22(6):438-9. PubMed ID: 9193832
[No Abstract] [Full Text] [Related]
9. 18F-fluorodeoxyglucose imaging in preoperative diagnosis of thyroid malignancy.
Joensuu H; Ahonen A; Klemi PJ
Eur J Nucl Med; 1988; 13(10):502-6. PubMed ID: 3371370
[TBL] [Abstract][Full Text] [Related]
10. 18F-fluorodeoxyglucose positron emission tomography does not predict malignancy in thyroid nodules cytologically diagnosed as follicular neoplasm.
Kim JM; Ryu JS; Kim TY; Kim WB; Kwon GY; Gong G; Moon DH; Kim SC; Hong SJ; Shong YK
J Clin Endocrinol Metab; 2007 May; 92(5):1630-4. PubMed ID: 17284624
[TBL] [Abstract][Full Text] [Related]
11. [F-18-FDG PET in autonomous goiter].
Börner AR; Voth E; Wienhard K; Wagner R; Schicha H
Nuklearmedizin; 1999; 38(1):1-6. PubMed ID: 9987775
[TBL] [Abstract][Full Text] [Related]
12. Cervical lymph node metastasis of thyroid papillary carcinoma imaged with fluorine-18-FDG, technetium-99m-pertechnetate and iodine-131-sodium iodide.
Scott GC; Meier DA; Dickinson CZ
J Nucl Med; 1995 Oct; 36(10):1843-5. PubMed ID: 7562053
[TBL] [Abstract][Full Text] [Related]
13. The Rate and Clinical Significance of Incidental Thyroid Uptake as Detected by Gallium-68 DOTATATE Positron Emission Tomography/Computed Tomography.
Nockel P; Millo C; Keutgen X; Klubo-Gwiezdzinska J; Shell J; Patel D; Nilubol N; Herscovitch P; Sadowski SM; Kebebew E
Thyroid; 2016 Jun; 26(6):831-5. PubMed ID: 27094616
[TBL] [Abstract][Full Text] [Related]
14. [Positron emission tomography (PET) with fludeoxyglucose F 18 in the study of adrenal masses: comparison of benign and malignant lesions].
Maurea S; Mainolfi C; Wang H; Varrella P; Panico MR; Klain M; Rossi R; Cremona F; Bazzicalupo L; Salvatore M
Radiol Med; 1996 Dec; 92(6):782-7. PubMed ID: 9122472
[TBL] [Abstract][Full Text] [Related]
15. Glucose metabolism of the thyroid in autonomous goiter measured by F-18-FDG-PE.
Boerner AR; Voth E; Theissen P; Wienhard K; Wagner R; Schicha H
Exp Clin Endocrinol Diabetes; 2000; 108(3):191-6. PubMed ID: 10926315
[TBL] [Abstract][Full Text] [Related]
16. Clinical significance of focal and diffuse thyroid diseases identified by (18)F-fluorodeoxyglucose positron emission tomography.
Salvatori M; Melis L; Castaldi P; Maussier ML; Rufini V; Perotti G; Rubello D
Biomed Pharmacother; 2007 Sep; 61(8):488-93. PubMed ID: 17604940
[TBL] [Abstract][Full Text] [Related]
17. [18FDG whole-body PET in differentiated thyroid carcinoma. Flipflop in uptake patterns of 18FDG and 131I].
Feine U; Lietzenmayer R; Hanke JP; Wöhrle H; Müller-Schauenburg W
Nuklearmedizin; 1995 Aug; 34(4):127-34. PubMed ID: 7675641
[TBL] [Abstract][Full Text] [Related]
18. Imaging of metastases of thyroid carcinoma with fluorine-18 fluorodeoxyglucose.
Joensuu H; Ahonen A
J Nucl Med; 1987 May; 28(5):910-4. PubMed ID: 3572549
[TBL] [Abstract][Full Text] [Related]
19. An evaluation of FDG-PET in the detection and differentiation of thyroid tumours.
Sasaki M; Ichiya Y; Kuwabara Y; Akashi Y; Yoshida T; Fukumura T; Masuda K
Nucl Med Commun; 1997 Oct; 18(10):957-63. PubMed ID: 9392798
[TBL] [Abstract][Full Text] [Related]
20. Uptake of 18-fluoro-2-deoxy-D-glucose by thyroid cancer: implications for diagnosis and therapy.
Sisson JC; Ackermann RJ; Meyer MA; Wahl RL
J Clin Endocrinol Metab; 1993 Oct; 77(4):1090-4. PubMed ID: 8408458
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]